Why outpatient appointments shouldn’t gate access to diagnostics
Modern healthcare is increasingly driven by diagnostic information. From imaging and physiological testing to pathology and screening, clinical decisions are rarely made on consultation alone; yet many outpatient pathways continue to follow a model where patients must first wait for a specialist appointment before investigations can even be requested.
The result is a familiar and frustrating cycle – patients are referred, wait weeks or months for an outpatient consultation, attend an appointment that often serves primarily to request tests, then wait again for diagnostics before a clinical decision can be reached. Every additional step adds delay, consumes clinical capacity and extends the time patients spend living with uncertainty.
As NHS organisations continue seeking ways to improve elective recovery and outpatient productivity, a growing number are asking a different question: what if diagnostics came first?
A fundamental shift in pathway design
A diagnostics-first model challenges one of the longest-standing assumptions in outpatient care.
Traditionally, outpatient appointments have acted as the gateway to testing. In a redesigned pathway, diagnostics become the gateway to clinical decisions and, where necessary, outpatient appointments. Patients access the investigations needed to support decision-making as early as possible, enabling clinicians to review meaningful information sooner and focus appointments where they add genuine value.
The principle is simple: tests should gate access to appointments, not the other way around. By obtaining the right information earlier, providers can reduce unnecessary touchpoints, shorten pathways and make better use of limited clinical resources.
For patients, this means fewer delays and faster answers. For healthcare organisations, it means a more efficient route from referral to diagnosis and decision.
Community diagnostic centres as engines of transformation
Community Diagnostic Centres (CDCs) have become a central part of the NHS’s strategy for addressing diagnostic demand and improving access to tests. However, their greatest potential may extend beyond simply increasing capacity.
When combined with pathway redesign, CDCs can become powerful enablers of elective transformation. A diagnostics-first approach allows CDCs to move from being standalone testing facilities to becoming integral components of decision-led pathways. Instead of reacting to outpatient requests for investigations, they can proactively support earlier diagnosis, earlier clinical review and earlier discharge where appropriate.
By standardising investigations around specific symptoms or conditions and coordinating multiple diagnostic tests into a single attendance, CDCs can significantly reduce the number of steps required to reach a clinical decision.
The QVH breathlessness pathway
One of the clearest examples of this approach can be found in our Pathway Redesgn Playbook’s featured case study from Queen Victoria Hospital NHS Foundation Trust (QVH).
Traditionally, patients presenting with breathlessness may require input from multiple specialties, including respiratory and cardiology services. The conventional pathway often involves several outpatient appointments, multiple referrals and lengthy waits before reaching a definitive diagnosis.
Working with Feedback Medical, QVH redesigned the pathway around the key clinical decision rather than the sequence of appointments traditionally used to reach it. Patients are triaged earlier and attend their CDC for coordinated diagnostic testing before unnecessary outpatient appointments take place. Clinicians then review the information digitally and collaborate remotely across specialties to determine the most appropriate course of action.
As Dr Matthew Lees, Deputy Chief Medical Officer and Clinical Lead for Pathways and Physiological Studies at QVH, explains:
Delivering measurable results
The redesigned pathway has demonstrated how digital coordination and earlier diagnostics can transform patient flow.
As of August 2026, the pathway had achieved:
- An average active pathway length of just five weeks.
- A longest pathway length of 12 weeks, including triage, bundled respiratory diagnostics, respiratory review and cardiology diagnostics.
- More than 90% of patients discharged back to primary care without requiring an outpatient appointment.
Perhaps most importantly, consultant time is focused on patients who genuinely require specialist intervention rather than administrative or investigatory appointments that add limited clinical value.
Diagnostics as the driver of flow
The experience at QVH highlights a broader lesson for healthcare leaders. Pathways do not move because appointments happen. Pathways move because decisions happen, and decisions depend on information.
By bringing diagnostics to the beginning of the pathway, organisations can ensure clinicians have the evidence they need sooner, enabling earlier diagnosis, earlier treatment planning and earlier discharge where appropriate.
This approach also creates opportunities to improve productivity without simply adding more capacity. Feedback Medical’s modelling suggests that reducing avoidable outpatient activity through diagnostics-first pathway design, while making better use of existing diagnostic infrastructure, could increase RTT throughput by around 30% without additional system cost.
Looking beyond traditional outpatient care
As demand continues to rise, simply expanding the existing outpatient model is unlikely to be enough. The greatest opportunity lies in redesigning the pathway itself.
CDCs have already transformed access to testing; the next challenge is to use that capability to transform how patients move through care. By placing diagnostics at the centre of pathway design, NHS organisations can reduce delays, improve patient experience and help more people reach the right clinical decision sooner.
Because when diagnostics flow, decisions flow; and when decisions flow, pathways move faster.
Read the Pathway Redesign Playbook here